Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin crossover biomarker study in fasted and postprandial healthy participants
NL-OMON50416Completed
- Sponsor
- Novo Nordisk
- Start
- Dec 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of heparin, sponsored by Novo Nordisk. Started Dec 2021; status: completed.
02
Drugs
heparin
Beyond the preview
Go deeper on NL-OMON50416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50416.